A platform investment in health manufacturing infrastructure.
Kraetr represents a structural opportunity to build permanent manufacturing capability in a market defined by complete import dependency and strong institutional demand signals.
Five structural advantages.
Zero Competition
No manufacturer in East Africa produces medical-grade nonwoven fabrics or the finished surgical and hygiene products that depend on them. Kraetr is building the category.
Structural Cost Advantage
Vertical integration from raw resin to finished product eliminates imported intermediate material costs and multi-tier supply chain margins.
Institutional Demand
National procurement systems, health ministries, and public health programmes across the EAC represent predictable, recurring institutional demand.
Policy Tailwind
Rwanda’s industrial, trade, and health policies explicitly prioritise domestic manufacturing of medical consumables. Kraetr is aligned with stated national strategy.
AfCFTA Market Access
The African Continental Free Trade Area opens a 1.4 billion-person addressable market for manufactured medical goods produced on the continent.
Structured for bankability.
The project is financed through a conventional project finance structure combining senior debt from a multilateral development bank with equity from institutional and strategic partners.
Multilateral development bank facility. Indicative term sheet received following full Information Memorandum submission and project finance review.
Combination of institutional equity, strategic industrial partnership, and sponsor commitment. Equity raise currently active.
From financial close to commissioning.
Pre-Construction
Construction
Commissioning
Operations
Interested in the opportunity?
We welcome conversations with institutional investors, strategic industrial partners, and development finance institutions aligned with our mission.